Placebo-controlled Study Comparing Niraparib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab as Maintenance Therapy in Participants With Advanced/Metastatic Non-Small Cell Lung Cancer

Clinical trial NCT04475939 · COMPLETED

Trial details

NCT number: NCT04475939
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Lung Cancer, Non-Small Cell

Start date: 2020-10-26
Primary completion: 2025-02-26
Enrollment: 666

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.